RQM+ is a global MedTech service provider focused on accelerating compliance and market success. Through our unparalleled expertise and industry knowledge, we deliver specialized solutions and expedite the journey along the full product lifecycle for Med Device and IVD companies, from concept to commercialization to post-market.

Our portfolio of services enables the delivery of end-to-end solutions across the complete med device product lifecycle, with our: 
• Regulatory and Quality Consulting
• Lab Services (Jordi Labs)
• Clinical Trials
• Reimbursement
• Technology Solutions


RQM+

RQM+ welcomes Michelle Tarver, M.D., Ph.D., Deputy Center Director for Transformation, FDA, CDRH, to a panel discussion aimed at increasing awareness and understanding of equity in the medical device and IVD space.

#### Objectives:

1.  \*\*Regulatory Expectations: \*\*Examining health equity concerns, regulatory efforts to promote equity, and FDA requirements for enhancing diversity in clinical trials
2.  \*\*Healthcare at Home: \*\*Exploring the "Home as a Healthcare Hub" initiative and its implications for health equity, including the challenges and opportunities of integrating healthcare services at home
3.  \*\*Industry Perspectives: \*\*Providing insights from industry leaders on how medical device companies are addressing health equity, with a focus on real-world examples and action plans
4.  \*\*Action Plans and Strategies: \*\*Sharing best practices for developing and implementing plans that assess diversity, explore risks, and identify actions to address health equity within medical device companies
5.  \*\*Interactive Q\&A: \*\*Offering an opportunity for participants to engage with experts, ask questions, and gain a deeper understanding of the topic

**Complete the form on this page to stay ahead of these critical regulatory changes and ensure the continued success of your sterilization processes.**

We hope to see you on Thursday, 8 August!

**Panelists:**

*   Michelle Tarver, M.D., Ph.D. –Deputy Center Director for Transformation, FDA, CDRH
*   Allison Komiyama, Ph.D., RAC – Vice President, MedTech Innovations, RQM+
*   Jon Gimbel, Ph.D. – Vice President of Technical, RQM+
*   Brandy Chittester – Senior Director, Clinical Operations, RQM+
*   Jaishankar (Jai) Kutty, Ph.D. – Vice President, Global Regulatory Affairs, RQM+ (moderator)

*Certificate of Participation available upon request for live attendees.*
